Old Web
English
Sign In
Acemap
>
Paper
>
Value-Based pricing and the end of pharmaceutical pricing as we know it? A case study on sorafenib and axitinib
Value-Based pricing and the end of pharmaceutical pricing as we know it? A case study on sorafenib and axitinib
2017
Panagiotis Petrou
Keywords:
Axitinib
Value-based pricing
Biochemistry
Biology
Sorafenib
Pharmacology
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
4
Citations
NaN
KQI
[]